Hidden health benefits from weight-loss shots revealed
The research also suggests that individuals with type 2 diabetes and obesity who are prescribed these medications could face a reduced risk of premature death.
Academics behind the study noted that while the efficacy of GLP agonist drugs – such as semaglutide (found in Wegovy and Ozempic) and tirzepatide (Mounjaro) – in managing weight and blood sugar levels is widely recognised, their wider health benefits have remained less understood.
The comprehensive study, conducted by experts in Taiwan, examined data from 60,000 people worldwide, with an average age of 58, all diagnosed with type 2 diabetes and obesity.
Roughly half of the participants were given GLP agonist drugs.
These medications function by curbing appetite, slowing digestion, reducing the liver's sugar output, and enhancing the body's insulin production when required.
The other half used other anti-diabetic medication.
During a seven-year follow-up period, researchers found that people given the GLP agonist drugs appeared to have a 37 per cent lower risk of dementia and a 19 per cent reduced risk of stroke.
They were also 30 per cent less likely to die during the follow-up period.
When researchers looked at the data further, they found even greater benefits in people aged 60 or older, women, and those with a body mass index score of 30 to 40.
They found no differences in Parkinson's disease or brain bleeds.
The academics said their findings suggest 'potential neuroprotective and cerebrovascular benefits' of the drugs but they called for more studies to confirm the findings.
'These findings suggest that semaglutide and tirzepatide may offer neuroprotective and cerebrovascular benefits beyond glycemic control, potentially improving long-term cognitive and survival outcomes in adults with type 2 diabetes and obesity,' they wrote in the journal JAMA Network Open.
Commenting on the study, Professor Tara Spires-Jones, director of the Centre for Discovery Brain Sciences at the University of Edinburgh and group leader in the UK Dementia Research Institute, said: 'This is a very interesting study adding to evidence that GLP1 receptor agonists are associated with a lower risk of dementia in people with type 2 diabetes and obesity.
'This type of study cannot determine whether the drugs reduced disease risk by directly protecting the brain.
'It is highly likely that effectively treating type 2 diabetes and obesity would reduce dementia and stroke risk as they are known risk factors for these conditions.
'Further work is needed including randomised clinical trials to confirm these drugs are protective in people with diabetes and obesity and other trials are needed to determine whether these drugs will be protective in people who do not have type 2 diabetes and obesity.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
5 hours ago
- Daily Mail
EXCLUSIVE REVEALED: Weight loss injections now linked to FIVE deaths in Scotland
Fat jabs have been linked to the deaths of five people in Scotland, including one reported to watchdogs this year. The prescription-only drugs, originally developed to suppress appetite among obese patients with type 2 diabetes, have become popular as a quick fix for people looking to lose weight. However, health watchdogs have received hundreds of reports from people who have become ill after taking them. In March, the Medicines and Healthcare Regulatory Agency (MHRA) disclosed it had been notified 361 times since January last year of patients in Scotland who have suffered illness after taking the drugs. MailOnline recently reported that 12 Scots were taken to A&E between April 2023 and August 2024 with complications from weight loss injections in the same health board area where Britain's first fat jab victim died. Now, the watchdog has revealed details of the most serious cases linked to the drugs in Scotland, stating it has received five reports of fatalities. Three reports concerned patients using the medications for weight loss alone while a fourth patient had prescriptions to treat diabetes. Details of the fifth reported fatality were not provided. Nurse Susan McGowan became the first person in the UK whose death was directly linked to a weight-loss jab. She died at Monklands Hospital in Airdrie last September. The 58-year-old suffered organ failure, septic shock and pancreatitis after taking two jabs of 'prescribed tirzepatide', sold under the brand name Mounjaro. Dr Samantha Robson, a GP working in weight management, said it is important not to draw conclusions on the deaths without clear clinical context. She said the drugs can be 'transformational medications when used correctly, for the right patients, with the right support', but added that there are instances of people taking them improperly. She said: 'Many patients are accessing these medications privately—through clinics, prescribers, and worryingly, through unregulated online pharmacies and social media.' Dr Robson is the medical director of Temple Clinic in Aberdeen, which prescribes GLP-1 medications 'under strict medical supervision and with intensive support'. However, she said it is alarmingly easy for people to obtain them without proper assessment, supervision or education. 'I am aware of cases where patients with a history of eating disorders, including anorexia nervosa, are lying about their weight and health to access these drugs purely to suppress appetite and further restrict their intake. This is deeply dangerous. 'There are also growing reports of counterfeit medications being sold online—products that may be contaminated, contain no active ingredient, or in some cases may be resold used pens from patients who stopped the medication but are hoping to recoup some cost.' She added: 'These medications are not inherently dangerous — but unsupervised, unregulated use absolutely is. And if we continue to allow them to be used like crash diets in injectable form, the current headlines will be the tip of the iceberg. This is not just a public health issue — it's an ethical one.' MailOnline has previously revealed that black market seizures in Scotland of potentially dangerous weight loss drugs have soared. The MHRA is investigating whether a genetic trait puts some patients at greater risk of side effects. Dr Alison Cave, its chief safety officer, said: 'Patient safety is our top priority and no medicine would be approved unless it met our expected standards of safety, quality and effectiveness. 'On the basis of the current evidence, the benefits of GLP-1 medicines outweigh the potential risks when used for the licensed indications. The decision to start, continue or stop treatments should be made jointly by patients and their doctor, based on full consideration of the benefits and risks.'
Daily Mail
6 hours ago
- Daily Mail
Two key factors of dementia risk that outweigh all others
Tackling hearing loss early and making an effort to maintain social relationships could delay the development of dementia later in life, promising new research has found. Studies have long suggested that around four in ten cases of the memory-robbing condition could be preventable. Addressing vision loss, treating depression and doing plenty of exercise are all ways of reducing the risk. Now Swiss scientists, who tracked more than 30,000 adults, have revealed a significant link between hearing loss, loneliness and memory decline. Writing in the journal Communications Psychology, scientists at the University of Geneva said: 'Addressing hearing impairment alongside loneliness—even in socially integrated individuals—may be crucial for promoting cognitive health in later life. With increasing longevity, understanding the relationship between hearing impairment and cognitive functioning is of utmost importance for ageing societies.' In the study, the researchers analysed 33,741 adults aged 50 and over enrolled in the Survey of Health, Ageing and Retirement in Europe (SHARE). Over a 17 year period they found that older adults who said they felt lonely—even if they were not socially isolated—showed steeper cognitive decline as their hearing deteriorated compared to socially integrated individuals. Participants who were both isolated and lonely consistently performed worse across all cognitive tasks including immediate and delayed recall and verbal fluency. According to the researchers, this could be because memory processes like retrieving information are used more by people who interact with others on a regular basis. Additionally, researchers found that lonely individuals found hearing loss more distressing than their non-lonely peers, highlighting the psychological burden of the condition which could contribute to memory loss. The researchers concluded that their findings support the theory that both objective and subjective social isolation are relevant to dementia risk. 'Our design uncovered a significant role for loneliness in shaping the extent to which sensory decline is linked to cognition,' the researchers added. However, the researchers acknowledged that causality could not be inferred. They added: 'Our findings indicate that both hearing impairment and psychosocial factors such as loneliness and social isolation may be relevant to cognitive functioning in later life. This underscores the importance of a holistic approach that combines auditory health with psychosocial support to maintain cognitive health in later life.' In response to studies such as this, experts at Alzheimer's Research UK are now calling on the government to include a hearing check in the NHS Health Check for over-40s. Dr Isolde Radford, from the charity, said: 'We don't yet know if hearing loss directly causes dementia or whether it causes other conditions that, in turn increase our risk. What we do know is that hearing loss, like dementia, isn't an inevitable part of ageing. This simple step could help millions identify hearing loss earlier and take appropriate action, such as wearing hearing aids, that may help reduce their risk of dementia.' It comes as a landmark study last year also suggested almost half of all Alzheimer's cases could be prevented by tackling 14 lifestyle factors. To reduce dementia risk throughout life, the commission also made 13 recommendations for both people and governments. These include making hearing aids available for all those who need it, reducing harmful noise exposure, and increased detection and treatment access for high cholesterol among the over-40s. Experts claimed the study, published in medical journal The Lancet, provided more hope than 'ever before' that the memory-robbing disorder that blights the lives of millions can be prevented. Alzheimer's Disease is the most common form of dementia and affects 982,000 people in the UK. It is thought to be caused by a build-up of amyloid and tau in the brain, which clump together and from plaques and tangles that make it harder for the brain to work properly. Eventually, the brain struggles to cope with this damage and dementia symptoms develop. Memory problems, thinking and reasoning difficulties and language problems are common early symptoms of the condition, which then worsen over time. Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country's biggest killer.
Times
10 hours ago
- Times
I used to think it was a waste of money keeping an old dog alive
O ur border collie had a stroke at the weekend and it turns out I'm a hypocrite. Five years ago I watched in disbelief as a friend spent thousands of pounds he didn't have on improbable surgery for his 12-year-old dog. It wasn't even one of the good dogs. It was a pug with a face that looked like it was pressed against a dirty window and a cough like it smoked 40 a day. My friend loved that dog, though, and no amount of reason could convince him that it was time to let go. A wheelbarrow of money and six months' rehabilitation later, the pug had recovered. Another eight months passed and it died of old age. I resolved then not to make the same mistake. 'When Floss is old we're not going to spend a fortune keeping her alive for our benefit,' I announced, all man of the house. Harriet and the kids seemed to take it well.
